Auvi-q Generic Name & Formulations
Legal Class
Rx
General Description
Epinephrine 0.1mg, 0.15mg, 0.3mg; pre-filled auto-injector (includes audible and visible cues for use).
Pharmacological Class
Sympathomimetic.
How Supplied
Cartons—2 (w. one Auvi-Q Trainer)
Manufacturer
Generic Availability
NO
Auvi-q Indications
Indications
Emergency treatment of allergic reactions (Type 1) including anaphylaxis.
Auvi-q Dosage and Administration
Adults and Children
<7.5kg: not established. Inject IM or SQ only into the anterolateral aspect of the thigh. 7.5–15kg: 0.1mg. 15–30kg: 0.15mg. ≥30kg: 0.3mg. May repeat another dose if needed.
Auvi-q Contraindications
Not Applicable
Auvi-q Boxed Warnings
Not Applicable
Auvi-q Warnings/Precautions
Warnings/Precautions
The presence of sulfite in this product should not deter use. Cardiovascular disease. Hypertension. Hyperthyroidism. Diabetes. Parkinson's disease. Injection-related complications: do not inject intravenously or into buttock (risk of Clostridial infections), digits, hands, or feet; hold leg firmly and limit movement in children prior to and during injection. Advise patient to seek medical help immediately. Train patient in use of device. Elderly. Pregnancy (Cat.C). Nursing mothers.
Auvi-q Pharmacokinetics
See Literature
Auvi-q Interactions
Interactions
May be potentiated by MAOIs, tricyclic antidepressants, levothyroxine, antihistamines (eg, chlorpheniramine, tripelennamine, diphenhydramine). May be antagonized by β-blockers (eg, propranolol), α-blockers (eg, phentolamine), ergot alkaloids. Arrhythmias possible with cardiac glycosides, diuretics, or anti-arrhythmics.
Auvi-q Adverse Reactions
Adverse Reactions
Anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea, vomiting, headache, respiratory difficulties; arrhythmias; rare: serious infections (skin and soft tissue) at injection site.
Auvi-q Clinical Trials
See Literature
Auvi-q Note
Not Applicable
Auvi-q Patient Counseling
See Literature
Images
